Brief: Apellis Pharmaceuticals Q1 Basic EPS USD -0.54
May 07 (Reuters) - Apellis Pharmaceuticals Q1 operating income USD -62.09 million. * Q1 operating expenses USD 234.415 million * Q1 net income USD -66.423 million * Q1 product revenue USD 163.075 million